Uroial™

Innovative and targeted therapeutic approach in the treatment of Cystitis

Uroial™

UROIAL™ is a unique combination that, with its synergistic effect, anti-adhesive, anti-inflammatory, protective, and regenerative, presents an effective solution in the therapy of acute and repeated inflammation of the bladder and the urethra.

Effects:

Uropathogenic bacteria are the main causes of inflammation of the bladder and urinary tract. Escherichia coli is the most common bacterium that causes urinary tract infections. These bacteria use fimbriae, fimbriae type 1 and fimbriae type P, to attach to the uroepithelium – the mucous membrane of the urinary tract.

ANTIADHESIVE AND ANTI-INFLAMMATORY EFFECT

S&R PACs and D-MANNOSE inhibit the adhesion of the uropathogenic bacterium Escherichia coli to the urothelial epithelium through a competitive pathway by binding to the fimbriae (types 1 and P). Fimbriae type 1 – mannose-sensitive fimbriae and type P – mannose-resistant and PACs-sensitive fimbriae.

S&R PACTM the patent is an exclusive mixture of cranberry that combines dry extract with powder of the whole fruit and ensures the utilization of all active components present in the phytocomplex, rich not only in protocyanides but also in organic acids, flavonoids, vitamin C, catechins, and triterpenes.

S&R PACs are type A PAC which are pharmacologically active on bacterial fimbriae (type P).

S&R PACs the mixture allows the anti-adhesive effect to be combined with the anti-inflammatory effect, thanks to the presence of organic acids such as phenolic acids and their derivatives, which are able to inhibit the inflammatory response and mediate the release of pro-inflammatory cytokines.

D-MANNOSE is a simple sugar that, once absorbed into the body, is not used, but is eliminated through the kidneys, reaching high concentrations in the urinary tract where it exerts its antibacterial effect. It has a high affinity for type 1 (mannose-sensitive) fimbriae, because its structure is very similar to the binding site of cellular glycoprotein receptors.

PROTECTIVE AND ANTIOXIDATIVE EFFECT

HYALURON ACID and CHONDROITIN SULFATE represent the main molecules that make up glycosoaminoglycans (GAG), the polysaccharides that are spread evenly across the urothelium as a cover, and hence prevent the toxic effect of molecules from urine on the epithelium of the urethra. If they are taken orally, through the mechanism of intestinal absorption and renal elimination, they reach the appropriate concentration in the bladder, where they restore the urothelium even in cases of interstitial cystitis.

*INTERSTITIAL CYSTITIS is a chronic syndrome characterized by the progressive destruction of the surface layer of the bladder, which consists of GAG.

VITAMIN C has a known antioxidant effect that helps strengthen the body’s defenses. Lowering the pH of urine increases its acidity and thus contributes to the creation of an unfavorable environment for the proliferation of bacteria.

Proven clinical effectiveness:

Composition:

Active ingredients

2 stick packets

(daily dose)

 

% NRV*

D-mannose

1000 mg

/

S&R PACTM

(a mixture of fruit powder and cranberry extract Vaccinium macrocarpon)

of which  proanthocyanidins PAC

250 mg

 

72 mg

/

 

 

/

Chondroitin sulfate

200 mg

/

Vitamin C

120 mg

150

Hyaluronic acid

100 mg

/

Indication and route of administration:

  • In the treatment of Cystitis as a natural health product suplemental to antibiotics:

Dissolve two packets a day directly in the mouth for 7 days and then one packet a day for at least a week.

  • In prophylaxis in patients prone to frequent urinary infections:

Dissolve one sachet a day directly in the mouth for at least 14 days.

UROIAL™ does not contain gluten and lactose. Safe to take while pregnant.

Warning:

Do not use the product in case of known hypersensitivity to any ingredient. The product contains polyols, excessive consumption may have a laxative effect.

Packaging:

14 orodispersible packets

Write to us

10 + 4 =

Mosorska 9, 11000 Belgrade, Serbia

Vemax011 Pharma doo representative office Northern Macedonia - Dane Krapcev 13, Skopje

Vemax011 Pharma doo representative office Montenegro - Topliški put 1, Budva

Vemax011 Pharma doo representative office Bosnia and Hercegovina - Vlakovo 252, Sarajevo

+381 (0)69 801 47 87

office@vemaxpharma.rs

Vemax Pharma - your trusted regional partner on the road to health!